However, this mutation is thought to potentially weaken the interaction of HOXB13 with its MEIS cofactor, and the HOXB13/MEIS interaction in turn has been shown to reduce prostate cancer metastasis by blocking the expression of specific proteoglycans.100. This evidence concerns the gene HOXB13 and prostate cancer.